The Trump administration is in discussions to take a direct equity stake in Intel, according to Bloomberg. This is not a bailout rumor. It is a structural intervention in the only remaining American company capable of leading-edge semiconductor fabrication. Intel's board has resisted this outcome, but the company's financials have made resistance increasingly untenable. Intel publicly announced it would halt process node development beyond 14A, a move the author reads as a deliberate distress signal: fund us or watch the foundry die.
Intel's decline is not a recent story. The company invented the microprocessor, commercial DRAM, strained silicon, high-k metal gates, and FinFETs. Its founding lineage runs from Shockley Semiconductor through Fairchild to Bob Noyce. That legacy now sits inside a company that cannot self-finance its next generation of manufacturing nodes. The CPU business is shrinking in strategic relevance. The foundry is not. No other American firm operates at the process nodes Intel is attempting. That asymmetry is why Washington is at the table.
The original piece, from Fabricated Knowledge, is worth reading in full not for the conclusion but for the board analysis. The author has documented Intel's governance failures across multiple pieces alongside SemiAnalysis, and the argument here is specific: the board has actively obstructed the restructuring Intel needs. Understanding why government intervention became the path of least resistance requires reading that institutional history, not just the Bloomberg headline.
[READ ORIGINAL →]